RBC Lowers Price Target on Pacira BioSciences to $37 From $42, Keeps Outperform Rating
RBC Lowers Price Target on Pacira BioSciences to $37 From $42, Keeps Outperform Rating
RBC将Pacira BioSciences的目标股价从42美元降至37美元,保持跑赢大盘评级。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册